Dugan Margaret

Track

Insider profile

Dugan Margaret's trades of BeOne Medicines AG's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
297.73
Quantity 5,559 -14.7%
Value US$3,528,624
Transaction date
Proposed sale
Price
310.87
Quantity 50,883
Value US$4,698,535
Transaction date
Planned sale
Price
162.87
Quantity 52,624 -35.0%
Value US$4,837,622
Transaction date
Proposed sale
Price
21.07
Quantity 1,395
Value US$29,387
Transaction date
Planned sale
Price
17.78
Quantity 1,531 -10.2%
Value US$27,226
Transaction date
Proposed sale
Price
17.78
Quantity 1,531
Value US$27,226
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-27 2026-05-22
S Sale
5,559 -14.7%
297.73
US$3,528,624 		5,559 -14.7% 297.73 US$3,528,624
2026-05-22 2026-05-22
PrS Proposed sale
50,883
310.87
US$4,698,535 		50,883 310.87 US$4,698,535
2025-10-17 2025-10-16
PlS Planned sale
52,624 -35.0%
162.87
US$4,837,622 		52,624 -35.0% 162.87 US$4,837,622
2025-10-16 2025-10-16
PrS Proposed sale
1,395
21.07
US$29,387 		1,395 21.07 US$29,387
2024-10-16 2024-10-15
PlS Planned sale
1,531 -10.2%
17.78
US$27,226 		1,531 -10.2% 17.78 US$27,226
2024-10-15 2024-10-15
PrS Proposed sale
1,531
17.78
US$27,226 		1,531 17.78 US$27,226